Breakthrough healthcare technologies in the COVID-19 era: a unique opportunity for cardiovascular practitioners and patients
The COVID-19 pandemic has reduced timely hospital admissions for ST-elevation myocardial infarction in Europe and the USA. We searched biomedical data...
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series
The coronavirus disease 2019 (COVID-19) pandemic continues to produce substantial morbidity and mortality. This work provides important insights into...
How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity
In this narrative review, we address potential mechanisms regarding viral transmission, physical reserve and the immune system. The highest mortality...
COVID-19 associated with severe autoimmune hemolytic anemia
Autoimmune hemolytic anemia (AIHA) has many known disease associations, including autoimmune, lymphoproliferative, and certain infectious diseases. St...
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates
An important unknown during the coronavirus disease- 2019 (COVID-19) pandemic has been the infection fatality rate (IFR) IFR is increasingly being cal...
Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients
Since early February 2021, the causative agent of COVID-19, SARS-CoV-2, has infected over 104 million people with more than 2 million deaths according...
Current Evidence of 2019 Novel Coronavirus Disease (COVID-19) Ocular Transmission: A Systematic Review and Meta-Analysis
We performed a systematic review and meta-analysis of 12 studies with 1930 participants. The pooled prevalence rate of conjunctivitis/conjunctival con...
Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis
Since the outbreak of coronavirus disease 2019 in China, numerous research institutions have invested in the development of anti-COVID-19 vaccines and...